| Common Name: | GP REPAIR MORTAR |
| Manufacturer: | LATICRETE INTERNATIONAL |
| SDS Revision Date: | 11/1/2012 |
| SDS Format: | No Format Specified |
| Item Number(s): | 46F424 |
| Manufacturer Model Number(s): |
SDS Table of Contents
Click the desired link below to jump directly to that section in the SDS.
LATICRETE(R*)
MATERIAL SAFETY DATA SHEET
FORM: F 7.3.29
REV: B
DATE: 01/25/07
| I. PRODUCT IDENTIFICATION |  |
TRADE NAME (AS LABELED): LATICRETE GP REPAIR MORTAR
CHEMICAL FAMILY: PROPRIETARY MIXTURE
MANUFACTURER'S NAME:
LATICRETE INTERNATIONAL, INC.
1 LATICRETE PARK, N.
BETHANY, CT 06524-3423
USA
PHONE NUMBER FOR ADDITIONAL INFORMATION: (203) 393-0010 OR
WEBSITE: WWW.LATICRETE.COM
DATE PREPARED OR REVISED: 11/2012
NAME OF PREPARER: S. B. FINE
| II. HAZARDOUS INGREDIENTS | |
CHEMICAL NAMES CAS NUMBERS PERCENT ACGIH TLV OSHA PEL OTHER
(SPECIFY)
CYSTALLINE 14808-60-7 35-45 N/A 0.1 MG/M3
SILICA
IN THE FORM OF
QUARTZ
SLAG 65996-69-2 10-15 N/A N/A
ANHYDRITE 14798-04-0 4-7 10 MG/M3 15 MG/M3
RESPIRABLE
CALCIUM SULFATE 10101-41-4 1-3 10 MG/M3 5 MG/M3
RESPIRABLE
LITHIUM 554-13-2 0.2-0.4 N/A 3 MG/M3
CARBONATE RESPIRABLE
POLYVINYL 25213-24-5 0.5-1.5 3 MG/M3 N/A
ALCHOHOL RESPIRABLE
PORTLAND CEMENT 65997-15-1 4-8 10 MG/M3 50 MPPCF
N/A = NOT APPLICABLE OR AVAILABLE
| III. HEALTH HAZARD INFORMATION | |
SYMPTOMS OF OVEREXPOSURE FOR EACH POTENTIAL ROUTE OF EXPOSURE. (POSSIBLE
LONGER TERM EFFECTS):
CHRONIC BRONCHITIS, POSSIBLE SILICOSIS, OR CANCER IF EXPOSED TO GREATER
THAN PERMISSIBLE LIMITS FOR A PROLONGED PERIOD OF TIME. EXPOSURE TO MORE
THAN 5 MG/M3 WITHOUT PROTECTION MAY CAUSE BIRTH DEFECTS IN PREGNANT WOMEN.
(ACUTE EFFECTS)
INHALED:
INHALED:
IRRITATION TO NOSE AND THROAT, LARGE DOSES MAY CAUSE TREMOR OR NAUSEA. MAY
CAUSE DAMAGE TO MUCOUS MEMBRANES OR RESPIRATORY TRACT.
CONTACT WITH SKIN OR EYES:
MAY CAUSE SKIN IRRITATION OR BURNS AND EYE IRRITATION OR BURNS
ABSORBED THROUGH SKIN: NOT LIKELY TO OCCUR
SWALLOWED:
CAN BE HARMFUL IF SWALLOWED. IRRITATION TO THROAT, NAUSEA, INHALATION OR
SWALLOWING OF LARGE DOSES (OVER 500 MG/KG OF BODY WEIGHT) MAY CAUSE TREMOR
OR NAUSEA
SUSPECTED CANCER AGENT?:
( ) NO: THIS PRODUCT'S INGREDIENTS ARE NOT FOUND IN THE LISTS BELOW.
YES:
( ) FEDERAL OSHA
( ) NTP
(X) IARC
| IV. FIRST AID | |
EMERGENCY PROCEDURES:
EYE CONTACT:
IRRIGATE IMMEDIATELY FOR AT LEAST 15 MINUTES. SEE A PHYSICIAN IF
IRRITATION PERSISTS.
SKIN CONTACT:
WASH OFF IN FLOWING WATER OR SHOWER. SEE A PHYSICIAN IF IRRITATION
PERSISTS.
INHALED: REMOVE TO FRESH AIR. SEEK MEDICAL ATTENTION IF NECESSARY.
SWALLOWED: SEEK IMMEDIATE MEDICAL ATTENTION.
| V. FIRE AND EXPLOSION | |
FLASH POINT (METHOD): N/A
AUTO IGNITION TEMPERATURE, DEG. F: N/A
FLAMMABLE LIMITS IN AIR, VOLUME %: N/A
LOWER (LEL):
UPPER (UEL):
FIRE EXTINGUISHING MATERIALS:
(X) WATER SPRAY
(X) FOAM
(X) CARBON DIOXIDE
(X) DRY CHEMICAL
( ) OTHER
SPECIAL FIRE FIGHTING PROCEDURES:
WEAR POSITIVE PRESSURE SELF-CONTAINED BREATHING APPARATUS.
UNUSUAL FIRE AND EXPLOSION HAZARDS:
THIS PRODUCT WILL NOT BURN. USE APPROPRIATE TECHNIQUES TO FIGHT
SURROUNDING FIRES.
| VI. SPILL, LEAK, AND DISPOSAL PROCEDURES | |
SPILL RESPONSE PROCEDURES (INCLUDE EMPLOYEE PROTECTION MEASURES):
DUST MASKS, SAFETY GLASSES, AND LONG SLEEVED CLOTHING; AVOID THE
GENERATION OF DUST. VACUUM OR SHOVEL MATERIAL AND PLACE IN A CLOSED
CONTAINER.
PREPARING WASTES FOR DISPOSAL (CONTAINER TYPES, NEUTRALIZATION, ETC.): N/A
NOTE:
DISPOSE OF ALL WASTES IN ACCORDANCE WITH FEDERAL, STATE AND LOCAL
REGULATIONS.
| VII. HANDLING AND STORAGE | |
WEAR DUST MASKS, SAFETY GLASSES, AND LONG SLEEVED CLOTHING WHEN HANDLING.
STORE IN DRY, WELL VENTILATED AREAS.
| VIII. EXPOSURE CONTROLS AND PERSONAL PROTECTION | |
VENTILATION AND ENGINEERING CONTROLS: NORMAL
RESPIRATORY PROTECTION (TYPE):
NIOSH APPROVED DUST MASKS IF EXPOSURE LIMITS ARE EXCEEDED.
EYE PROTECTION (TYPE): SAFETY GLASSES OR GOGGLES
GLOVES (SPECIFY MATERIAL): IMPERVIOUS GLOVES
OTHER CLOTHING AND EQUIPMENT: LONG SLEEVED CLOTHING
WORK PRACTICES, HYGIENIC PRACTICES: NORMAL GOOD HOUSEKEEPING
OTHER HANDLING AND STORAGE REQUIREMENTS: N/A
PROTECTIVE MEASURES DURING MAINTENANCE OF CONTAMINATED EQUIPMENT:
SEE ABOVE
| IX. PHYSICAL PROPERTIES | |
VAPOR DENSITY (AIR=1): N/A
SPECIFIC GRAVITY: N/A
SOLUBILITY IN WATER:
MELTING POINT OR RANGE, DEG. F: N/A
BOILING POINT OR RANGE, DEG. F: N/A
EVAPORATION RATE (): N/A
VAPOR PRESSURE, MMHg AT 20 DEG. C: N/A
APPEARANCE AND ODOR: LIGHT GREY ODORLESS POWDER
HOW TO DETECT THIS SUBSTANCE (WARNING PROPERTIES OF SUBSTANCE AS A GAS,
VAPOR, DUST, OR MIST): N/A
| X. REACTIVITY DATA | |
STABILITY:
(X) STABLE
( ) UNSTABLE
CONDITIONS TO AVOID: CONTACT WITH ACIDS.
INCOMPATIBILITY (MATERIALS TO AVOID): CONTACT WITH ACIDS.
HAZARDOUS DECOMPOSITION PRODUCTS (INCLUDING COMBUSTION PRODUCTS):
NONE KNOWN
HAZARDOUS POLYMERIZATION:
( ) MAY OCCUR
(X) WILL NOT OCCUR
CONDITIONS TO AVOID:
| XI. TOXICOLOGY INFORMATION | |
INHALATION; BREATHING SILICA DUST MAY NOT CAUSE NOTICEABLE INJURY OR
ILLNESS EVEN THOUGH PERMANENT LUNG DAMAGE MAY BE OCCURRING.
INHALATION OF DUST MAY HAVE THE FOLLOWING SERIOUS CHRONIC HEALTH EFFECTS:
SILICOSIS:
EXCESSIVE INHALATION OF RESPIRABLE CRYSTALLINE SILICA DUST MAY CAUSE A
PROGRESSIVE, DISABLING AND SOMETIMES FATAL LUNG DISEASE CALLED SILICOSIS.
SYMPTOMS INCLUDE COUGH, SHORTNESS OF BREATH. WHEEZING, NON-SPECIFIC CHEST
ILLNESS AND REDUCED PULMONARY FUNCTION. THIS DISEASE IS EXACERBATED BY
SMOKING. INDIVIDUALS WITH SILICOSIS ARE PREDISPOSED TO DEVELOP
MYCOBACTERIAL INFECTIONS, (TUBERCULOUS AND NON-TUBERCULOUS) AND FUNGAL
INFECTIONS. INHALATION OF AIR WITH A VERY HIGH CONCENTRATION OF RESPIRABLE
SILICA DUST CAN CAUSE THE MOST SERIOUS FORMS OF SILICOSIS IN A MATTER OF
MONTHS OR A FEW YEARS. SOME EPIDEMIOLOGIC STUDIES HAVE CONCLUDED THAT
THERE IS SIGNIFICANT RISK OF DEVELOPING SILICOSIS EVEN AT AIRBORNE
EXPOSURE LEVELS THAT ARE EQUAL TO THE RECOMMENDED NIOSH, REL, THE ACGIH
TLV, THE OSHA PEL, AND THE MSHA EXPOSURE LIMIT.
THEN:
IS SOME EVIDENCE THAT BREATHING RESPIRABLE CRYSTALLINE SILICA OR THE
DISEASE SILICOSIS IS ASSOCIATED WITH AN INCREASED INCIDENCE OF SIGNIFICANT
DISEASE ENDPOINTS SUCH AS SCLERODERMA (AN IMMUNE SYSTEM DISORDER
MANIFESTED BY FIBROSIS OF THE LUNGS. SKIN AND OTHER INTERNAL ORGANS)
RHEUMATOID ARTHRITIS. SYSTEMIC LUPUS, ERYTHEMATOSUS, SARCOIDOSIS, CHRONIC
BRONCHITIS, CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD). EMPHYSEMA.
CHRONIC KIDNEY DISEASE AND END-STAGE RENAL DISEASE.
| XII. ECOLOGICAL INFORMATION | |
THIS PRODUCT IS NOT EXPECTED TO PRESENT AN ENVIRONMENTAL HAZARD.
| XIII. DISPOSAL INFORMATION | |
DISPOSE IN COMPLIANCE WITH LOCAL, STATE, AND FEDERAL REGULATIONS. SPILLED
PRODUCT CAN BE RECOVERED AND REUSED.
| XIV. TRANSPORT INFORMATION | |
NOT REGULATED
| XV. REGULATORY INFORMATION | |
ALL INGREDIENTS ARE LISTED ON THE U.S. EPA TSCA INVENTORY OF CHEMICAL
SUBSTANCES.
W.H.M.I.S. CLASS: D.2.
THIS PRODUCT CONTAINS A CHEMICAL KNOWN TO THE STATE OF CALIFORNIA TO CAUSE
CANCER OR REPRODUCTIVE HARM.
| XVI. OTHER INFORMATION | |
THIS INFORMATION IS FURNISHED WITHOUT WARRANTY, REPRESENTATION, INDUCEMENT
OR LICENSE OF ANY KIND; EXCEPT THAT IT IS ACCURATE TO THE BEST OF OUR
KNOWLEDGE, OR OBTAINED FROM SOURCES BELIEVED BY US TO BE ACCURATE.